Nasdaq
XTLB
XTL Biopharmaceuticals Ltd.
- Health Care
- Israel
- 1 day
- +0.7%
- 1 month
- −3.7%
- 1 year
- −48.4%
$2.87 · Mkt cap $7.05M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
XTL Biopharmaceuticals Ltd.
$2.87 · Mkt cap $7.05M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
XTL Biopharmaceuticals Ltd. trades under the ticker XTLB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $7.05M. The last closing price was $2.87, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −48.4%, and −3.7% over the past month. Returns are price returns and exclude dividends.
This page exists because XTLB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.